| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 4.09e-05 | 9 | 160 | 3 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 4.09e-05 | 9 | 160 | 3 | GO:0001640 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid omega-hydroxylase activity | 6.38e-05 | 2 | 160 | 2 | GO:0140981 | |
| GeneOntologyMolecularFunction | 16-hydroxypalmitate dehydrogenase activity | 6.38e-05 | 2 | 160 | 2 | GO:0103002 | |
| GeneOntologyMolecularFunction | malate dehydrogenase (decarboxylating) (NADP+) activity | 1.90e-04 | 3 | 160 | 2 | GO:0004473 | |
| GeneOntologyMolecularFunction | malic enzyme activity | 3.79e-04 | 4 | 160 | 2 | GO:0004470 | |
| GeneOntologyMolecularFunction | oxaloacetate decarboxylase activity | 3.79e-04 | 4 | 160 | 2 | GO:0008948 | |
| GeneOntologyMolecularFunction | decanoate-CoA ligase activity | 3.79e-04 | 4 | 160 | 2 | GO:0102391 | |
| GeneOntologyMolecularFunction | iron ion binding | 3.89e-04 | 166 | 160 | 7 | GO:0005506 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 5.61e-04 | 127 | 160 | 6 | GO:0016616 | |
| GeneOntologyMolecularFunction | K48-linked deubiquitinase activity | 6.04e-04 | 21 | 160 | 3 | GO:1990380 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 8.67e-04 | 138 | 160 | 6 | GO:0016614 | |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 9.37e-04 | 6 | 160 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | fatty acid ligase activity | 1.15e-03 | 26 | 160 | 3 | GO:0015645 | |
| GeneOntologyMolecularFunction | CoA-ligase activity | 1.28e-03 | 27 | 160 | 3 | GO:0016405 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.28e-03 | 27 | 160 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 1.31e-03 | 7 | 160 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 1.31e-03 | 7 | 160 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.39e-03 | 206 | 160 | 7 | GO:0140030 | |
| GeneOntologyMolecularFunction | heme binding | 1.53e-03 | 154 | 160 | 6 | GO:0020037 | |
| GeneOntologyMolecularFunction | malate dehydrogenase activity | 1.73e-03 | 8 | 160 | 2 | GO:0016615 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA synthase activity | 1.73e-03 | 8 | 160 | 2 | GO:0004321 | |
| GeneOntologyMolecularFunction | acid-thiol ligase activity | 1.92e-03 | 31 | 160 | 3 | GO:0016878 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 2.10e-03 | 164 | 160 | 6 | GO:0046906 | |
| GeneOntologyBiologicalProcess | regulation of long-chain fatty acid import across plasma membrane | 1.45e-05 | 7 | 156 | 3 | GO:0010746 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway | 3.45e-05 | 9 | 156 | 3 | GO:0007196 | |
| GeneOntologyBiologicalProcess | regulation of long-chain fatty acid import into cell | 3.45e-05 | 9 | 156 | 3 | GO:0140212 | |
| GeneOntologyBiologicalProcess | skeletal muscle satellite cell migration | 5.68e-05 | 2 | 156 | 2 | GO:1902766 | |
| Domain | GPCR_3_mtglu_rcpt | 3.35e-05 | 8 | 160 | 3 | IPR000162 | |
| Domain | ARHGEF5_35 | 7.29e-05 | 2 | 160 | 2 | PF15441 | |
| Domain | ARHGEF5/35_N | 7.29e-05 | 2 | 160 | 2 | IPR029212 | |
| Domain | NCD3G | 1.66e-04 | 13 | 160 | 3 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 1.66e-04 | 13 | 160 | 3 | IPR011500 | |
| Domain | ATPase_dyneun-rel_AAA | 2.10e-04 | 14 | 160 | 3 | IPR011704 | |
| Domain | GPCR_3_CS | 2.10e-04 | 14 | 160 | 3 | IPR017979 | |
| Domain | AAA_5 | 2.10e-04 | 14 | 160 | 3 | PF07728 | |
| Domain | Malic_OxRdtase | 2.18e-04 | 3 | 160 | 2 | IPR001891 | |
| Domain | Malic_NAD-bd | 2.18e-04 | 3 | 160 | 2 | IPR012302 | |
| Domain | Malic_N_dom | 2.18e-04 | 3 | 160 | 2 | IPR012301 | |
| Domain | MALIC_ENZYMES | 2.18e-04 | 3 | 160 | 2 | PS00331 | |
| Domain | Malic_M | 2.18e-04 | 3 | 160 | 2 | PF03949 | |
| Domain | Malic_M | 2.18e-04 | 3 | 160 | 2 | SM00919 | |
| Domain | malic | 2.18e-04 | 3 | 160 | 2 | PF00390 | |
| Domain | - | 2.18e-04 | 3 | 160 | 2 | 3.40.50.10380 | |
| Domain | USP7_C2 | 2.18e-04 | 3 | 160 | 2 | PF14533 | |
| Domain | malic | 2.18e-04 | 3 | 160 | 2 | SM01274 | |
| Domain | Malic_enzyme_CS | 2.18e-04 | 3 | 160 | 2 | IPR015884 | |
| Domain | USP_C | 2.18e-04 | 3 | 160 | 2 | IPR029346 | |
| Domain | Cyt_P450_E_grp-I | 5.88e-04 | 45 | 160 | 4 | IPR002401 | |
| Domain | RHO | 6.32e-04 | 20 | 160 | 3 | PS51420 | |
| Domain | Na/HCO3_transpt | 7.17e-04 | 5 | 160 | 2 | IPR003024 | |
| Domain | GPCR_3 | 7.33e-04 | 21 | 160 | 3 | IPR000337 | |
| Domain | 7tm_3 | 8.43e-04 | 22 | 160 | 3 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 8.43e-04 | 22 | 160 | 3 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 8.43e-04 | 22 | 160 | 3 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 8.43e-04 | 22 | 160 | 3 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 8.43e-04 | 22 | 160 | 3 | PS50259 | |
| Domain | GPCR_3_C | 8.43e-04 | 22 | 160 | 3 | IPR017978 | |
| Domain | TUDOR | 9.63e-04 | 23 | 160 | 3 | PS50304 | |
| Domain | - | 1.07e-03 | 6 | 160 | 2 | 2.40.50.90 | |
| Domain | Staphylococal_nuclease_OB-fold | 1.07e-03 | 6 | 160 | 2 | IPR016071 | |
| Domain | Cyt_P450_CS | 1.10e-03 | 53 | 160 | 4 | IPR017972 | |
| Domain | AMP-binding_CS | 1.39e-03 | 26 | 160 | 3 | IPR020845 | |
| Domain | CYTOCHROME_P450 | 1.44e-03 | 57 | 160 | 4 | PS00086 | |
| Domain | Mob1_phocein | 1.49e-03 | 7 | 160 | 2 | PF03637 | |
| Domain | MOB_kinase_act_fam | 1.49e-03 | 7 | 160 | 2 | IPR005301 | |
| Domain | - | 1.49e-03 | 7 | 160 | 2 | 1.20.140.30 | |
| Domain | Mob1_phocein | 1.49e-03 | 7 | 160 | 2 | SM01388 | |
| Domain | - | 1.54e-03 | 58 | 160 | 4 | 1.10.630.10 | |
| Domain | p450 | 1.54e-03 | 58 | 160 | 4 | PF00067 | |
| Domain | TUDOR | 1.55e-03 | 27 | 160 | 3 | SM00333 | |
| Domain | AMP_BINDING | 1.73e-03 | 28 | 160 | 3 | PS00455 | |
| Domain | Cyt_P450 | 1.74e-03 | 60 | 160 | 4 | IPR001128 | |
| Domain | Tudor | 2.11e-03 | 30 | 160 | 3 | IPR002999 | |
| Domain | AMP-binding | 2.11e-03 | 30 | 160 | 3 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 2.11e-03 | 30 | 160 | 3 | IPR000873 | |
| Domain | USP_CS | 2.47e-03 | 66 | 160 | 4 | IPR018200 | |
| Domain | - | 2.52e-03 | 9 | 160 | 2 | 3.40.1100.10 | |
| Domain | Band3_cytoplasmic_dom | 2.52e-03 | 9 | 160 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 2.52e-03 | 9 | 160 | 2 | PF07565 | |
| Domain | USP_1 | 3.07e-03 | 70 | 160 | 4 | PS00972 | |
| Domain | PTrfase/Anion_transptr | 3.14e-03 | 10 | 160 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 3.14e-03 | 10 | 160 | 2 | IPR003020 | |
| Domain | HCO3_cotransp | 3.14e-03 | 10 | 160 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 3.14e-03 | 10 | 160 | 2 | IPR011531 | |
| Domain | UCH | 3.23e-03 | 71 | 160 | 4 | PF00443 | |
| Domain | USP_2 | 3.23e-03 | 71 | 160 | 4 | PS00973 | |
| Domain | USP_3 | 3.40e-03 | 72 | 160 | 4 | PS50235 | |
| Domain | USP_dom | 3.40e-03 | 72 | 160 | 4 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 3.40e-03 | 72 | 160 | 4 | IPR001394 | |
| Domain | ANF_lig-bd_rcpt | 3.87e-03 | 37 | 160 | 3 | IPR001828 | |
| Domain | Pkinase_C | 3.87e-03 | 37 | 160 | 3 | IPR017892 | |
| Domain | ANF_receptor | 3.87e-03 | 37 | 160 | 3 | PF01094 | |
| Domain | CYCLIN | 4.18e-03 | 38 | 160 | 3 | SM00385 | |
| Domain | Peripla_BP_I | 4.50e-03 | 39 | 160 | 3 | IPR028082 | |
| Domain | - | 4.83e-03 | 40 | 160 | 3 | 1.10.472.10 | |
| Domain | Pkinase_C | 5.55e-03 | 42 | 160 | 3 | PF00433 | |
| Domain | Cyclin-like | 5.92e-03 | 43 | 160 | 3 | IPR013763 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.20e-03 | 14 | 160 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 6.20e-03 | 14 | 160 | 2 | IPR013602 | |
| Domain | DHC_N2 | 6.20e-03 | 14 | 160 | 2 | PF08393 | |
| Domain | - | 6.20e-03 | 14 | 160 | 2 | 3.10.20.30 | |
| Domain | Beta-grasp_dom | 6.20e-03 | 14 | 160 | 2 | IPR012675 | |
| Domain | TUDOR | 6.20e-03 | 14 | 160 | 2 | PF00567 | |
| Domain | AAA_8 | 6.20e-03 | 14 | 160 | 2 | PF12780 | |
| Domain | DHC_fam | 7.12e-03 | 15 | 160 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 7.12e-03 | 15 | 160 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 7.12e-03 | 15 | 160 | 2 | IPR004273 | |
| Pathway | REACTOME_EICOSANOIDS | 1.78e-06 | 12 | 112 | 4 | M27129 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.78e-06 | 12 | 112 | 4 | M27128 | |
| Pathway | REACTOME_EICOSANOIDS | 1.78e-06 | 12 | 112 | 4 | MM14845 | |
| Pathway | REACTOME_FATTY_ACIDS | 4.82e-06 | 15 | 112 | 4 | M27126 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 4.83e-06 | 5 | 112 | 3 | MM15221 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 1.06e-05 | 18 | 112 | 4 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 1.06e-05 | 18 | 112 | 4 | MM14841 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 1.67e-05 | 7 | 112 | 3 | MM15217 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 2.04e-05 | 21 | 112 | 4 | M27137 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS | 3.96e-05 | 9 | 112 | 3 | M27551 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 4.20e-05 | 25 | 112 | 4 | MM14858 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 7.69e-05 | 11 | 112 | 3 | MM15046 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 1.14e-04 | 32 | 112 | 4 | M14309 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 1.29e-04 | 33 | 112 | 4 | MM15027 | |
| Pathway | REACTOME_S_PHASE | 1.62e-04 | 146 | 112 | 7 | MM15378 | |
| Pathway | REACTOME_G1_S_TRANSITION | 1.77e-04 | 104 | 112 | 6 | MM15376 | |
| Pathway | REACTOME_REGULATION_OF_TP53_DEGRADATION | 1.83e-04 | 36 | 112 | 4 | MM15339 | |
| Pathway | REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION | 2.04e-04 | 37 | 112 | 4 | M27641 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 2.07e-04 | 15 | 112 | 3 | MM15845 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 2.07e-04 | 15 | 112 | 3 | MM15037 | |
| Pathway | WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE | 2.07e-04 | 15 | 112 | 3 | M39442 | |
| Pathway | REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY | 2.32e-04 | 70 | 112 | 5 | MM15389 | |
| Pathway | WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY | 2.51e-04 | 39 | 112 | 4 | M39905 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR | 2.54e-04 | 16 | 112 | 3 | M47978 | |
| Pathway | SA_TRKA_RECEPTOR | 3.06e-04 | 17 | 112 | 3 | M18895 | |
| Pathway | REACTOME_S_PHASE | 3.18e-04 | 163 | 112 | 7 | M3158 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 4.31e-04 | 19 | 112 | 3 | M27493 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 4.31e-04 | 19 | 112 | 3 | M27489 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 4.33e-04 | 80 | 112 | 5 | M800 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 5.04e-04 | 20 | 112 | 3 | M18415 | |
| Pathway | WP_EBOLA_VIRUS_INFECTION_IN_HOST | 5.66e-04 | 129 | 112 | 6 | M39693 | |
| Pathway | REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY | 5.73e-04 | 85 | 112 | 5 | M27674 | |
| Pathway | PID_ECADHERIN_KERATINOCYTE_PATHWAY | 5.85e-04 | 21 | 112 | 3 | M184 | |
| Pathway | REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION | 5.90e-04 | 130 | 112 | 6 | MM15146 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY | 6.16e-04 | 5 | 112 | 2 | M48999 | |
| Pathway | WP_SILDENAFIL_TREATMENT | 7.70e-04 | 23 | 112 | 3 | M46455 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 7.70e-04 | 23 | 112 | 3 | MM15216 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 8.75e-04 | 24 | 112 | 3 | M2243 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY | 9.19e-04 | 6 | 112 | 2 | M47523 | |
| Pathway | WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION | 9.89e-04 | 25 | 112 | 3 | M39384 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 9.89e-04 | 25 | 112 | 3 | M14301 | |
| Pathway | BIOCARTA_RACCYCD_PATHWAY | 1.11e-03 | 26 | 112 | 3 | M14512 | |
| Pathway | WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES | 1.11e-03 | 26 | 112 | 3 | M48054 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 1.11e-03 | 26 | 112 | 3 | MM15017 | |
| Pathway | BIOCARTA_RACCYCD_PATHWAY | 1.11e-03 | 26 | 112 | 3 | MM1423 | |
| Pathway | PID_CXCR4_PATHWAY | 1.20e-03 | 100 | 112 | 5 | M124 | |
| Pathway | REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION | 1.20e-03 | 149 | 112 | 6 | M848 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.23e-03 | 59 | 112 | 4 | M27140 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY | 1.28e-03 | 7 | 112 | 2 | M47407 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 1.28e-03 | 7 | 112 | 2 | M47790 | |
| Pathway | REACTOME_AMINO_ACID_CONJUGATION | 1.28e-03 | 7 | 112 | 2 | MM14598 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.39e-03 | 61 | 112 | 4 | MM14861 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.48e-03 | 62 | 112 | 4 | M39653 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | NUP85 RB1 ORC3 HDAC8 PSMD1 PHF8 CCNA1 PDS5A AKT1 AKT2 PLK1 BORA | 1.65e-03 | 561 | 112 | 12 | M5336 |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.66e-03 | 64 | 112 | 4 | M5650 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 1.70e-03 | 8 | 112 | 2 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.70e-03 | 8 | 112 | 2 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.70e-03 | 8 | 112 | 2 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 1.70e-03 | 8 | 112 | 2 | M47404 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 1.70e-03 | 8 | 112 | 2 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 1.70e-03 | 8 | 112 | 2 | M47803 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 1.70e-03 | 8 | 112 | 2 | M47715 | |
| Pathway | REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION | 1.70e-03 | 8 | 112 | 2 | M27806 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.70e-03 | 8 | 112 | 2 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.70e-03 | 8 | 112 | 2 | M47498 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.86e-03 | 66 | 112 | 4 | MM14839 | |
| Pathway | PID_P75_NTR_PATHWAY | 2.08e-03 | 68 | 112 | 4 | M153 | |
| Pathway | WP_MELANOMA | 2.08e-03 | 68 | 112 | 4 | M39811 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 2.17e-03 | 9 | 112 | 2 | M47397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 2.17e-03 | 9 | 112 | 2 | M47392 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 2.17e-03 | 9 | 112 | 2 | M47391 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 2.17e-03 | 9 | 112 | 2 | M47402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 2.17e-03 | 9 | 112 | 2 | M47802 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 2.17e-03 | 9 | 112 | 2 | MM15666 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00482 | 2.17e-03 | 9 | 112 | 2 | M47578 | |
| Pathway | REACTOME_AMINO_ACID_CONJUGATION | 2.17e-03 | 9 | 112 | 2 | M26968 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 2.17e-03 | 9 | 112 | 2 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 2.17e-03 | 9 | 112 | 2 | M47481 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 2.17e-03 | 9 | 112 | 2 | M39819 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY | 2.17e-03 | 9 | 112 | 2 | M47972 | |
| Pathway | KEGG_PPAR_SIGNALING_PATHWAY | 2.19e-03 | 69 | 112 | 4 | M13088 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 2.22e-03 | 115 | 112 | 5 | M9387 | |
| Pathway | WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION | 2.24e-03 | 33 | 112 | 3 | M39745 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 2.24e-03 | 33 | 112 | 3 | M39503 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 2.24e-03 | 33 | 112 | 3 | MM1448 | |
| Pubmed | CYLD ACSL6 NCKAP1 GON4L PHF8 EPG5 RPAP1 GPCPD1 COBL YY1AP1 USP15 MEGF11 DOP1B | 7.93e-08 | 407 | 164 | 13 | 12693553 | |
| Pubmed | RhoA, RhoB and RhoC have different roles in cancer cell migration. | 1.03e-07 | 3 | 164 | 3 | 23488932 | |
| Pubmed | A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells. | 1.03e-07 | 3 | 164 | 3 | 12939257 | |
| Pubmed | 1.03e-07 | 3 | 164 | 3 | 29500478 | ||
| Pubmed | RhoA, RhoB and RhoC differentially regulate endothelial barrier function. | 1.03e-07 | 3 | 164 | 3 | 28949796 | |
| Pubmed | 1.03e-07 | 3 | 164 | 3 | 19477269 | ||
| Pubmed | 1.03e-07 | 3 | 164 | 3 | 9271096 | ||
| Pubmed | 1.03e-07 | 3 | 164 | 3 | 22673745 | ||
| Pubmed | 1.03e-07 | 3 | 164 | 3 | 26741994 | ||
| Pubmed | 1.03e-07 | 3 | 164 | 3 | 15642170 | ||
| Pubmed | Spatiotemporal analysis of RhoA/B/C activation in primary human endothelial cells. | 1.03e-07 | 3 | 164 | 3 | 27147504 | |
| Pubmed | 1.93e-07 | 129 | 164 | 8 | 23022380 | ||
| Pubmed | Cooperation between mDia1 and ROCK in Rho-induced actin reorganization. | 4.10e-07 | 4 | 164 | 3 | 10559899 | |
| Pubmed | XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC. | 4.10e-07 | 4 | 164 | 3 | 12221096 | |
| Pubmed | Only Akt1 is required for proliferation, while Akt2 promotes cell cycle exit through p21 binding. | 4.10e-07 | 4 | 164 | 3 | 16982699 | |
| Pubmed | Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein. | 4.10e-07 | 4 | 164 | 3 | 15197186 | |
| Pubmed | 4.10e-07 | 4 | 164 | 3 | 8662891 | ||
| Pubmed | 4.10e-07 | 4 | 164 | 3 | 22992742 | ||
| Pubmed | 1.02e-06 | 5 | 164 | 3 | 8617235 | ||
| Pubmed | 1.02e-06 | 5 | 164 | 3 | 15093731 | ||
| Pubmed | 1.02e-06 | 5 | 164 | 3 | 8543060 | ||
| Pubmed | Small GTP-binding proteins and the regulation of the actin cytoskeleton. | 2.04e-06 | 6 | 164 | 3 | 7888179 | |
| Pubmed | 2.04e-06 | 6 | 164 | 3 | 9438836 | ||
| Pubmed | 2.04e-06 | 6 | 164 | 3 | 19286565 | ||
| Pubmed | 2.04e-06 | 6 | 164 | 3 | 23028142 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | RB1 EPB41L4B KIF26B PHF8 ECPAS BIRC6 RHOA PDE12 MDN1 RPAP1 EDAR AGL PDS5A SAMD3 DOP1B | 2.38e-06 | 736 | 164 | 15 | 29676528 |
| Pubmed | EPS15 NUP85 NCKAP1 ORC3 ZMYND8 PSMD1 VPS16 ECPAS PDE12 UTP4 PDS5A COG5 PLK1 | 2.85e-06 | 560 | 164 | 13 | 35241646 | |
| Pubmed | 3.55e-06 | 7 | 164 | 3 | 9920659 | ||
| Pubmed | RHO binding to FAM65A regulates Golgi reorientation during cell migration. | 3.55e-06 | 7 | 164 | 3 | 27807006 | |
| Pubmed | 3.55e-06 | 7 | 164 | 3 | 17634444 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EPS15 TMEM144 MYCBP2 EPB41L4B C11orf54 HDAC8 RDH10 PSMD1 ECPAS YJEFN3 SELENON ATP10A SFMBT2 HPS3 DNAH1 MALT1 GUCY1A1 ENTPD1 NEMF COBL USP15 | 7.68e-06 | 1489 | 164 | 21 | 28611215 |
| Pubmed | PI3K-AKT pathway mediates growth and survival signals during development of fetal mouse lung. | 8.47e-06 | 9 | 164 | 3 | 15695173 | |
| Pubmed | 8.47e-06 | 9 | 164 | 3 | 15151987 | ||
| Pubmed | Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. | 1.21e-05 | 10 | 164 | 3 | 9069281 | |
| Pubmed | 1.36e-05 | 31 | 164 | 4 | 36114200 | ||
| Pubmed | 1.36e-05 | 378 | 164 | 10 | 34315543 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | HK2 NUP85 NCKAP1 RB1 ORC3 ZMYND8 BEND4 CPS1 ECPAS MDN1 ZFHX4 AGL PDS5A COG5 MGA | 1.46e-05 | 857 | 164 | 15 | 25609649 |
| Pubmed | 1.65e-05 | 11 | 164 | 3 | 23077641 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 27878243 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 33162807 | ||
| Pubmed | Crosstalk between the Rb pathway and AKT signaling forms a quiescence-senescence switch. | 2.21e-05 | 2 | 164 | 2 | 24703840 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 27699769 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 21454503 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 15611369 | ||
| Pubmed | Akt inhibition promotes hexokinase 2 redistribution and glucose uptake in cancer cells. | 2.21e-05 | 2 | 164 | 2 | 23629924 | |
| Pubmed | Activation of a bacterial virulence protein by the GTPase RhoA. | 2.21e-05 | 2 | 164 | 2 | 19887681 | |
| Pubmed | Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma. | 2.21e-05 | 2 | 164 | 2 | 31252679 | |
| Pubmed | Akt1 is critical for acute inflammation and histamine-mediated vascular leakage. | 2.21e-05 | 2 | 164 | 2 | 19622728 | |
| Pubmed | Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients. | 2.21e-05 | 2 | 164 | 2 | 28271235 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 3283705 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 17019809 | ||
| Pubmed | Functional analysis of the promoters of the small GTPases RhoA and RhoB in embryonic stem cells. | 2.21e-05 | 2 | 164 | 2 | 28739254 | |
| Pubmed | Akt mediates Ras downregulation of RhoB, a suppressor of transformation, invasion, and metastasis. | 2.21e-05 | 2 | 164 | 2 | 15169915 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 33377281 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 12808121 | ||
| Pubmed | Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin. | 2.21e-05 | 2 | 164 | 2 | 9620559 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 11861503 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 12808085 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 15010337 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 36229454 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 28960175 | ||
| Pubmed | Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase. | 2.21e-05 | 2 | 164 | 2 | 23641057 | |
| Pubmed | Akt2 regulates cardiac metabolism and cardiomyocyte survival. | 2.21e-05 | 2 | 164 | 2 | 16950770 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 20332370 | ||
| Pubmed | AKT has an anti-apoptotic role in ABCA12-deficient keratinocytes. | 2.21e-05 | 2 | 164 | 2 | 21633372 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 3037531 | ||
| Pubmed | Newly identified Gon4l/Udu-interacting proteins implicate novel functions. | 2.21e-05 | 2 | 164 | 2 | 32848183 | |
| Pubmed | USP7 deubiquitinates epigenetic reader ZMYND8 to promote breast cancer cell migration and invasion. | 2.21e-05 | 2 | 164 | 2 | 39128723 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 32078465 | ||
| Pubmed | Hierarchical requirement of SWI/SNF in retinoblastoma tumor suppressor-mediated repression of Plk1. | 2.21e-05 | 2 | 164 | 2 | 15105433 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 33619771 | ||
| Pubmed | Functional roles of the tetramer organization of malic enzyme. | 2.21e-05 | 2 | 164 | 2 | 19416979 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 23076793 | ||
| Pubmed | Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. | 2.21e-05 | 2 | 164 | 2 | 19110052 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 23919516 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 28912346 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 17804734 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 24413902 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 27408773 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 17141631 | ||
| Pubmed | PI3K/AKT Signaling in Breast Cancer Molecular Subtyping and Lymph Node Involvement. | 2.21e-05 | 2 | 164 | 2 | 31781306 | |
| Pubmed | The transcriptional regulator GON4L is required for viability and hematopoiesis in mice. | 2.21e-05 | 2 | 164 | 2 | 33864850 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 30692211 | ||
| Pubmed | Distinct actions of akt1 on skeletal architecture and function. | 2.21e-05 | 2 | 164 | 2 | 24663486 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 20503409 | ||
| Pubmed | Guanine nucleotide exchange regulates membrane translocation of Rac/Rho GTP-binding proteins. | 2.21e-05 | 2 | 164 | 2 | 7989340 | |
| Pubmed | Polo-like kinase 1 regulates RhoA during cytokinesis exit in human cells. | 2.21e-05 | 2 | 164 | 2 | 17635521 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 19491266 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 8031839 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 33825439 | ||
| Pubmed | Akt1 and Akt2 are required for alphabeta thymocyte survival and differentiation. | 2.21e-05 | 2 | 164 | 2 | 17609365 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 17825284 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 10860550 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 20828398 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 31847370 | ||
| Pubmed | Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis. | 2.21e-05 | 2 | 164 | 2 | 26654940 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 15668138 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 16923802 | ||
| Pubmed | Role of AMPK and Akt in triple negative breast cancer lung colonization. | 2.21e-05 | 2 | 164 | 2 | 33839456 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 21432781 | ||
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 9.85e-06 | 8 | 103 | 3 | 281 | |
| GeneFamily | Cytochrome P450 family 4 | 5.09e-05 | 36 | 103 | 4 | 1003 | |
| GeneFamily | Rho family GTPases | 1.91e-04 | 20 | 103 | 3 | 390 | |
| GeneFamily | Ubiquitin specific peptidases | 2.91e-04 | 56 | 103 | 4 | 366 | |
| GeneFamily | Acyl-CoA synthetase family | 4.24e-04 | 26 | 103 | 3 | 40 | |
| GeneFamily | MOB kinase activators|STRIPAK complex | 6.63e-04 | 7 | 103 | 2 | 647 | |
| GeneFamily | Tudor domain containing | 1.21e-03 | 37 | 103 | 3 | 780 | |
| GeneFamily | Dyneins, axonemal | 4.13e-03 | 17 | 103 | 2 | 536 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPS15 NCKAP1 MYCBP2 RB1 KDM4C TRPC1 DDR2 ZMYND8 USP24 PHF8 EFR3A MALT1 MDN1 USP7 PDS5A PARN COG5 USP15 DOP1B | 1.17e-06 | 856 | 159 | 19 | M4500 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-08 | 184 | 160 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-08 | 184 | 160 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-08 | 184 | 160 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | pdx-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.25e-07 | 182 | 160 | 8 | 7b24a4f712e1ae1525e8f1c8ec4e1fc43489cbee | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.92e-07 | 197 | 160 | 8 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-06 | 160 | 160 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-06 | 160 | 160 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-06 | 171 | 160 | 7 | 5d0d6c1ff610a703ae0b834a12823c5ff9012932 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.92e-06 | 179 | 160 | 7 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | (05)_Ciliated-(4)_1wkpi|(05)_Ciliated / shred by cell type and Timepoint | 4.07e-06 | 180 | 160 | 7 | 85fc9b164147b28545e2397d32302eea03ef6346 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-06 | 185 | 160 | 7 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.87e-06 | 195 | 160 | 7 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.87e-06 | 195 | 160 | 7 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.35e-06 | 197 | 160 | 7 | d6c9da7a3a6d2bcb13e2fc6605c8a59e7fb121c5 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.35e-06 | 197 | 160 | 7 | 80b05c8ad9c1edc5dea3236079372475431343fe | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 8.11e-06 | 200 | 160 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-05 | 161 | 160 | 6 | 1e17a993126e1f2a25ee7dfbb95a74ccb2a26791 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.06e-05 | 166 | 160 | 6 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.06e-05 | 166 | 160 | 6 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.06e-05 | 166 | 160 | 6 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.73e-05 | 172 | 160 | 6 | 80b565f6e37f38629f4cf89d5b053b3b8517244e | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-5|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 3.73e-05 | 172 | 160 | 6 | 6b8a8d3b97c10b9d092307eed3cacbd2745df185 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.85e-05 | 173 | 160 | 6 | a809be2630d2b91b53b82b5e2bb99e05524597c1 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 173 | 160 | 6 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 173 | 160 | 6 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 173 | 160 | 6 | 9dc7746a84f0e268a7c061e1bbcd5e31903034dc | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 176 | 160 | 6 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 178 | 160 | 6 | 9b932b677ae05ac6e12cd6ce97789f8c10e4790b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.66e-05 | 179 | 160 | 6 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.26e-05 | 183 | 160 | 6 | d73cac83cde82665f110baad7cf28db75f9ffe52 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.26e-05 | 183 | 160 | 6 | f4ea7113ce9099222743d9ff02388d3d8a9e987b | |
| ToppCell | facs-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 184 | 160 | 6 | dc7f6ee4062856a02423fff8b1cce62d46a9355c | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.43e-05 | 184 | 160 | 6 | 437bc6c983849c1c3ff85f0dee091cf7010a4665 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.43e-05 | 184 | 160 | 6 | d1d5dd1701dff4eedf1cebbb9f4cd603aa0009c1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.59e-05 | 185 | 160 | 6 | 03df43e9c2ce4ec24ffed8e4e2993f94ba951c8b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.59e-05 | 185 | 160 | 6 | dbdbd6593cd98550238519746bb45fbf0617550b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Endothelial_Myeloid-Endo|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.59e-05 | 185 | 160 | 6 | de2c24719946d5a37a982d816776cea7f3984c49 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.59e-05 | 185 | 160 | 6 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 5.93e-05 | 187 | 160 | 6 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.48e-05 | 190 | 160 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 6.67e-05 | 191 | 160 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.87e-05 | 192 | 160 | 6 | 3e1a4cb0d83efd502c8613d41a1692bdda5860ed | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.27e-05 | 194 | 160 | 6 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.27e-05 | 194 | 160 | 6 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.27e-05 | 194 | 160 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.27e-05 | 194 | 160 | 6 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-05 | 194 | 160 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.27e-05 | 194 | 160 | 6 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.48e-05 | 195 | 160 | 6 | e525b69145059b66417589601f7109af63730f3a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.48e-05 | 195 | 160 | 6 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.69e-05 | 196 | 160 | 6 | 4ebcaac758ed01d918de9c1cd383a84457b615f3 | |
| ToppCell | COVID-19_Mild-Neu_0|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 7.79e-05 | 63 | 160 | 4 | 1ab77b6f098686bc168427159282bbf3538d4292 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 7.91e-05 | 197 | 160 | 6 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | distal-3-Epithelial-Proximal_Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.91e-05 | 197 | 160 | 6 | 15b4d1203943ce90a7083178d4a4284d9b323071 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 8.14e-05 | 198 | 160 | 6 | 827aa9d919bf6d670961e5501e17d351676127e3 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.14e-05 | 198 | 160 | 6 | 3811d9e3e54bbe8b208c591697e43b55ab5bbf0e | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.14e-05 | 198 | 160 | 6 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Control_saline-Epithelial_alveolar|Control_saline / Treatment groups by lineage, cell group, cell type | 8.14e-05 | 198 | 160 | 6 | 532b7ef4ad46fe35ad2c6bdf89f70a17f1a2e2e2 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 8.60e-05 | 200 | 160 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 8.60e-05 | 200 | 160 | 6 | 5c7263c862093ad9dbc81d06b16b6f74e8a6b634 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 132 | 160 | 5 | 46c80eab16a70da9f363a9fbdf50bccab0b287d7 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 132 | 160 | 5 | a022c3c41654166cb106f27dc54fa88e8c40f898 | |
| Drug | clinoptilolite | 8.18e-06 | 19 | 159 | 4 | CID006336554 | |
| Drug | Dropropizine (R,S) [17692-31-8]; Up 200; 17uM; MCF7; HT_HG-U133A | 9.31e-06 | 194 | 159 | 9 | 5531_UP | |
| Drug | L000369 | 9.54e-06 | 41 | 159 | 5 | CID003931705 | |
| Drug | azetidine-2,4-dicarboxylic acid | 1.15e-05 | 7 | 159 | 3 | CID000005370 | |
| Drug | Simvastatin [79902-63-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.19e-05 | 200 | 159 | 9 | 3340_DN | |
| Drug | cis-MCG-I | 1.82e-05 | 8 | 159 | 3 | CID003035584 | |
| Drug | exoenzyme C3, Clostridium botulinum | 2.58e-05 | 25 | 159 | 4 | ctd:C063007 | |
| Drug | mM PEP | 2.72e-05 | 9 | 159 | 3 | CID005311462 | |
| Drug | AC1N21PP | 2.72e-05 | 9 | 159 | 3 | CID004014619 | |
| Drug | 1,3-cyclopentanedicarboxylic acid | 2.72e-05 | 9 | 159 | 3 | CID000107216 | |
| Drug | NS-105 | 3.87e-05 | 10 | 159 | 3 | CID000198695 | |
| Drug | 1-benzyl-apdc | 4.85e-05 | 2 | 159 | 2 | CID005310978 | |
| Drug | 2-methyl-5-(1-methylethenyl)cyclohexanol | 4.85e-05 | 2 | 159 | 2 | ctd:C534305 | |
| Drug | perillic acid | 4.85e-05 | 2 | 159 | 2 | ctd:C078706 | |
| Drug | cytotoxic necrotizing factor type 1 | 4.85e-05 | 2 | 159 | 2 | ctd:C060296 | |
| Drug | Ganciclovir [82410-32-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 5.25e-05 | 187 | 159 | 8 | 3368_DN | |
| Drug | cyclobutylene AP5 | 5.29e-05 | 11 | 159 | 3 | CID000126582 | |
| Drug | PBDA | 5.45e-05 | 30 | 159 | 4 | CID000004408 | |
| Disease | T-Cell Lymphoma | 1.30e-06 | 16 | 156 | 4 | C0079772 | |
| Disease | ulcerative colitis (implicated_via_orthology) | 5.00e-06 | 7 | 156 | 3 | DOID:8577 (implicated_via_orthology) | |
| Disease | peroxisomal biogenesis disorder (implicated_via_orthology) | 7.96e-06 | 8 | 156 | 3 | DOID:0080377 (implicated_via_orthology) | |
| Disease | salivary gland cancer (implicated_via_orthology) | 2.78e-05 | 2 | 156 | 2 | DOID:8850 (implicated_via_orthology) | |
| Disease | hypertension (biomarker_via_orthology) | 2.96e-05 | 227 | 156 | 8 | DOID:10763 (biomarker_via_orthology) | |
| Disease | Hypopigmentation disorder | 8.30e-05 | 3 | 156 | 2 | C0162835 | |
| Disease | Diffuse interstitial pulmonary fibrosis | 4.11e-04 | 6 | 156 | 2 | cv:C0085786 | |
| Disease | Cornelia de Lange syndrome (implicated_via_orthology) | 4.11e-04 | 6 | 156 | 2 | DOID:11725 (implicated_via_orthology) | |
| Disease | X-14939 measurement | 4.11e-04 | 6 | 156 | 2 | EFO_0800747 | |
| Disease | 10-undecenoate 11:1n1 measurement | 5.73e-04 | 7 | 156 | 2 | EFO_0021099 | |
| Disease | X-18899 measurement | 5.73e-04 | 7 | 156 | 2 | EFO_0800793 | |
| Disease | X-24748 measurement | 7.62e-04 | 8 | 156 | 2 | EFO_0022136 | |
| Disease | pimeloylcarnitine/3-methyladipoylcarnitine (C7-DC) measurement | 7.62e-04 | 8 | 156 | 2 | EFO_0800494 | |
| Disease | tyrosine-protein kinase receptor TYRO3 measurement | 7.62e-04 | 8 | 156 | 2 | EFO_0020829 | |
| Disease | Bladder Neoplasm | 9.10e-04 | 140 | 156 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 9.40e-04 | 141 | 156 | 5 | C0005684 | |
| Disease | membranous glomerulonephritis (implicated_via_orthology) | 9.76e-04 | 9 | 156 | 2 | DOID:10976 (implicated_via_orthology) | |
| Disease | 2-aminobutyrate measurement | 1.22e-03 | 10 | 156 | 2 | EFO_0020017 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.33e-03 | 41 | 156 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.33e-03 | 41 | 156 | 3 | C0858252 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 1.48e-03 | 11 | 156 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | Congenital Nonbullous Ichthyosiform Erythroderma | 1.48e-03 | 11 | 156 | 2 | C0079154 | |
| Disease | Congenital ichthyosis of skin | 1.48e-03 | 11 | 156 | 2 | cv:C0020758 | |
| Disease | unipolar depression, multiple sclerosis | 1.77e-03 | 12 | 156 | 2 | EFO_0003761, MONDO_0005301 | |
| Disease | undecenoylcarnitine (C11:1) measurement | 2.08e-03 | 13 | 156 | 2 | EFO_0800588 | |
| Disease | Hamman-Rich syndrome | 2.42e-03 | 14 | 156 | 2 | C0085786 | |
| Disease | urinary bladder cancer (is_marker_for) | 2.54e-03 | 107 | 156 | 4 | DOID:11054 (is_marker_for) | |
| Disease | response to statin, LDL cholesterol change measurement | 2.79e-03 | 15 | 156 | 2 | EFO_0007804, GO_0036273 | |
| Disease | anemia (implicated_via_orthology) | 2.79e-03 | 15 | 156 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | lipoprotein A measurement | 3.00e-03 | 112 | 156 | 4 | EFO_0006925 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 3.17e-03 | 16 | 156 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | amino acid measurement | 3.36e-03 | 678 | 156 | 10 | EFO_0005134 | |
| Disease | prostate cancer (is_implicated_in) | 3.51e-03 | 117 | 156 | 4 | DOID:10283 (is_implicated_in) | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 3.59e-03 | 17 | 156 | 2 | EFO_0022232 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 4.02e-03 | 18 | 156 | 2 | C0342384 | |
| Disease | Usual Interstitial Pneumonia | 4.48e-03 | 19 | 156 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 4.48e-03 | 19 | 156 | 2 | C4721508 | |
| Disease | level of Sterol ester (27:1/20:3) in blood serum | 4.48e-03 | 19 | 156 | 2 | OBA_2045199 | |
| Disease | serum metabolite measurement | TDRD15 KDM4C CYP4A11 KIF26B CYP4B1 DDR2 LAMB1 TM2D3 CPS1 GFUS CDK10 MEGF11 | 4.54e-03 | 945 | 156 | 12 | EFO_0005653 |
| Disease | Adenocarcinoma of lung (disorder) | 4.87e-03 | 206 | 156 | 5 | C0152013 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 4.96e-03 | 20 | 156 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | citrulline measurement | 4.96e-03 | 20 | 156 | 2 | EFO_0009777 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 4.96e-03 | 20 | 156 | 2 | C4721952 | |
| Disease | PR interval | 4.97e-03 | 495 | 156 | 8 | EFO_0004462 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VVGKPSPYMFECITE | 591 | Q6ZT62 | |
| MKTFCGTPEYLAPEV | 306 | P31749 | |
| TMKTFCGTPEYLAPE | 306 | P31751 | |
| EACTAPKMPEFILYA | 2036 | Q9HCE0 | |
| IKPLYCVPASMTLLF | 381 | P41214 | |
| KVTMFLQSPCPLYKG | 3821 | Q9NR09 | |
| DMILVPKVYTTLPIC | 1016 | Q8N7X0 | |
| CFSLYKDIINMPAGP | 781 | Q86UK0 | |
| IPYPCFMKDNFLTSV | 1051 | Q86UK0 | |
| DVCDYAIETMPSFPK | 66 | Q12774 | |
| YCMTFFFIAKPSPVI | 626 | Q14832 | |
| VTALEPDSPYKVCMV | 466 | Q9NZU0 | |
| PVPCQTVLDYLKMVL | 351 | Q6ZU67 | |
| DVCDYAIETMPSFPK | 66 | A5YM69 | |
| YTTMCIKEALRLYPP | 371 | Q02928 | |
| TLCSPPTVYRMLVQK | 316 | P0C7M7 | |
| CAKVIMDPYSAIPTS | 36 | A0A1B0GTU2 | |
| QSVPVYEMKFPDLCV | 806 | Q14156 | |
| DPVFYLTCLMTPVAA | 1271 | O60312 | |
| YKIPAICDMPTELHI | 1236 | Q06278 | |
| MSVPVAPKKSCYTQL | 1 | Q5JR59 | |
| CVLDYFIKLSPPMLL | 221 | P06400 | |
| METLYRVPFLVLECP | 1 | Q9NRP0 | |
| YPSIMTPKLCTQLTL | 131 | Q8NGY2 | |
| FIYICPFRALPADKM | 256 | A0A096LPK9 | |
| PLEYMAIFALCAKDP | 946 | Q29RF7 | |
| MLVTYDEPPYCIKAG | 51 | Q5JSJ4 | |
| YLFSVIVDPKEMPCF | 441 | Q96RS6 | |
| YCPLPADLSEFKEMT | 301 | O95453 | |
| EIAIDVAFLPMYCPE | 761 | Q6NSI4 | |
| VAFLPMYCPEDIRTS | 766 | Q6NSI4 | |
| YSLKSIDPVLMAPTC | 76 | P24863 | |
| DLMPYFQPSAIKCLP | 1046 | Q7RTW8 | |
| PILTCKLPESSYVEM | 951 | A6BM72 | |
| PRMVEFLKSSLYPCL | 116 | A9QM74 | |
| CSLPPSYCSKLVKVM | 1236 | Q9NU22 | |
| CMFVPKVYIILAKPE | 816 | P41594 | |
| KFMPIVYTPTVGLAC | 96 | P48163 | |
| AIPICAPYTTMTNYK | 996 | O60524 | |
| LDTGKMPVVYLEPCA | 461 | Q8IWI9 | |
| TSIVYKPPEIIMCDA | 616 | Q9UDY8 | |
| KPPEIIMCDAYVTDF | 621 | Q9UDY8 | |
| LTCVYIPKVMIEPSG | 251 | Q6UXI9 | |
| IYLSCFFLPVMSSEP | 26 | P61550 | |
| QPAICPDSVYKLMLS | 816 | Q16832 | |
| PFTMPVAILLYKVAC | 451 | Q3B7T1 | |
| KNVPIFVCTMAYPTV | 566 | Q17RB8 | |
| TCFKVLSKVQMPPSY | 531 | Q9Y3R5 | |
| CEGYIPMKTNITVYP | 1381 | Q2KJY2 | |
| IMFYILKTKPSAPAC | 206 | Q9UNE0 | |
| SCVPYKYVPISVLMI | 356 | O95972 | |
| KMVAIPTKYTYCPGI | 3581 | Q5CZC0 | |
| SAPVKMLPTYVCATP | 506 | P52789 | |
| PVMYCLLEAVSVYPE | 671 | Q5VYK3 | |
| PCIYSEVMEALKLQP | 66 | Q96MG8 | |
| EMVPSCPFIYIIRKD | 46 | Q9BW27 | |
| FADICYPSTTIPKMI | 66 | Q8NGB4 | |
| FVEICYCSVMAPKLI | 66 | Q8NH49 | |
| RYIMAGFPVCPKLSL | 171 | Q6L8Q7 | |
| PLKKFSDCSYIDPMT | 226 | Q9NX36 | |
| YIYMKQCVESSPLVP | 96 | Q6ZR08 | |
| KTKPLIPEMCFIYSE | 681 | Q9H3R0 | |
| LCKSYFPYLMAVLTP | 31 | Q6UX53 | |
| SPYTLIDSLVLMPYC | 696 | P07942 | |
| CIFPDKTTYPIDETM | 116 | Q13630 | |
| PIKCSAPKYIDYLMT | 106 | Q7L9L4 | |
| YVAICKPLRYPTIMS | 121 | Q6IEV9 | |
| LYKTPCTKRFEMTLP | 296 | P49961 | |
| QPPTCYVELKTSKEM | 246 | O77932 | |
| PFLTMDLLESCFPYV | 1096 | Q9Y2A7 | |
| PDVPCSLYMKELQGF | 636 | Q9UP83 | |
| SPDLKFFLCSMYTPI | 81 | Q9H461 | |
| KVCPFQPILYGDFMS | 2506 | Q9P2D7 | |
| CFEPSLDYMVTKIPR | 761 | P31327 | |
| DYIIIKPLPGYSCDM | 291 | Q9NPB8 | |
| EAKPIGFTMYTTCII | 781 | O15303 | |
| SYFKEKPLPCEPELM | 321 | Q15131 | |
| MFYSIDLSPVKCRSP | 226 | Q6PGQ7 | |
| SKVPCYLIVLTDGMS | 541 | A8TX70 | |
| YTTMCIKEALRLYPP | 371 | Q5TCH4 | |
| KASKYLCVSLMEPPA | 446 | P78396 | |
| TTYKIIPPKSEMRCY | 706 | O75128 | |
| MVPRIFAPAYVSVCL | 1 | Q6UWQ7 | |
| SKVFMYPELLPVCSL | 801 | Q3T8J9 | |
| ITDKVMPACLPSPDY | 1916 | P08519 | |
| KVFGNYIPVPATDCM | 646 | Q9UHN6 | |
| KFMPIVYTPTVGLAC | 131 | Q16798 | |
| IRCFKILLDPYSSMP | 46 | P0C2S0 | |
| LTMCIKESFRLYPPV | 366 | P13584 | |
| LVYCALEKEPVPMSL | 191 | P42566 | |
| SPEYVSMCDSLAKIP | 21 | Q9BY41 | |
| VTPCPEVGEYLKMSL | 906 | Q9NQC7 | |
| ILLPPVMACVADSFY | 521 | O75155 | |
| VPINNCYLMSKEIPF | 316 | Q9ULU4 | |
| VCMYPPIKTRLIKTF | 796 | Q9H329 | |
| DNYIPCTLEPVFGKM | 1616 | O75923 | |
| PFTTMCIKESLRQYP | 386 | Q6NT55 | |
| PIKMTSKPCYYTQEL | 306 | Q68DL7 | |
| GPLPEMVFCKYTKQI | 1156 | Q56UN5 | |
| CYIMKIAPESIPSLE | 121 | P11686 | |
| LRDYISSLKMTPCIP | 186 | Q86X27 | |
| PLSYPDTDVILMCFS | 71 | P08134 | |
| PYVVSLQAKDCPDMK | 131 | Q9UBD5 | |
| VFICTSPIKMFKYCP | 126 | Q9NPB1 | |
| SHFVPKPIEVCMYRE | 196 | P61328 | |
| KEVPSFGMLTPALCY | 1136 | Q8NET4 | |
| MVIPVGPTCEKYALQ | 701 | A2RTX5 | |
| AYMFCIIDKSLPLPN | 601 | Q969X6 | |
| PLSYPDTDVILMCFS | 71 | P61586 | |
| PLSYPDTDVILMCFS | 71 | P62745 | |
| SPLPQEVVMSLSKCY | 576 | Q9HAU8 | |
| LPMYVVFKRCLPLVT | 101 | Q5M8T2 | |
| PFCSETPQETYKKVM | 321 | Q15208 | |
| ACMVGAINPELYKFP | 121 | Q9BQS2 | |
| CMLPTIFAIVRYKPS | 631 | Q7Z5M5 | |
| ALKNPFYSLEMPIRC | 181 | Q9Y296 | |
| RGLVTPPMKTYIVFC | 71 | Q8NEQ6 | |
| SVYFPLMQNCLEIKP | 746 | O60522 | |
| ARFLKPSVCYKMEPV | 1206 | B5MCY1 | |
| FGECPYCSKPITLKM | 356 | Q9NW38 | |
| YIIEMPLSEAPLCIS | 126 | Q969F9 | |
| HRCSEPMFTIVYPKL | 316 | Q86X40 | |
| TCCAPVKTKPLSMLY | 311 | Q96S42 | |
| SYVLPEFPYDVKCML | 146 | Q8N6K7 | |
| PIKCSAPKYIDYLMT | 106 | Q9H8S9 | |
| IPCMIPFVPVAYDTS | 71 | A0PJY2 | |
| YKVKSCSMAPPVDLL | 361 | Q9BQS7 | |
| VLTMPETCRYQPFKP | 891 | Q99460 | |
| PIMVYQTKSPVPLTC | 326 | Q9H156 | |
| PACVMHYKVTFPECV | 2031 | O75592 | |
| LVSKNFLLPSVPYAM | 406 | Q9BVR0 | |
| PAPVTEEMLQRCKYS | 421 | Q8NA69 | |
| YVVAFSDEMVPCPVT | 411 | P10155 | |
| PATIPILMVFCAAYA | 241 | Q96J65 | |
| IKTTLVCPYLVDTGM | 236 | Q8IZV5 | |
| KPVRPVSLFMCYEGD | 421 | Q08AH1 | |
| LSDDMKALCPTIFPV | 351 | Q9UKU0 | |
| YEMKAPLVCLPVFVS | 241 | Q9H0W9 | |
| PFNIIPSPKTICYMI | 681 | P48995 | |
| CDYYMEEKVLPPSSL | 66 | Q8WWU5 | |
| YITLCIVFLMTCKPP | 116 | Q9Y320 | |
| NKFCFPVPYSRALIM | 196 | Q8N2M4 | |
| MEKFLDPSRPYKCTV | 1486 | Q86UP3 | |
| ECFYQPMPLKASLEI | 46 | Q9Y3A6 | |
| DICSKYTPDIVPMEK | 146 | Q9NXC5 | |
| CVMTKIFYLSPEGKT | 511 | Q6IEE8 | |
| PKDSMTLLPCFYFVE | 11 | Q6T4P5 | |
| CIAMKNSPKLYPEAV | 251 | Q7Z5S9 | |
| CMVLIDYAIGIPSPK | 771 | Q6U841 | |
| LEKYSFPVEMMICLP | 516 | Q9NZV5 | |
| VLNPMPACFYTVSRK | 171 | Q9ULZ2 | |
| KSPIGYLPFVEICMK | 751 | Q9H269 | |
| MCEPFYISPASVTKV | 311 | Q5VUG0 | |
| VALKGYSMVTCIFPP | 256 | P16471 | |
| QCEKMDIPFLSYLPT | 166 | A6XGL0 | |
| FCYLTLPLPMKKERT | 461 | Q9Y4E8 | |
| PSLYKVPCATAMKLL | 611 | Q9BWH6 | |
| PGEDMICQLYISKPF | 196 | Q8N841 | |
| PVYKSFLMSLCPRPE | 206 | Q00722 | |
| ATSKVFMYPELLPVC | 276 | Q9H869 | |
| FMYPELLPVCSLKAK | 281 | Q9H869 | |
| PYYPCMAKVSLQLAI | 2156 | Q9UPU5 | |
| MSLGCPLFKPELIYQ | 46 | Q08ER8 | |
| KMASVPVYCLCRLPY | 36 | Q9UPP1 | |
| CPYSEKVPSIKIPMD | 1036 | Q9Y6R1 | |
| YTPISCKIRDLLPVM | 706 | Q93009 | |
| AESTEIPPYVMKCPS | 56 | Q9BRN9 | |
| MYTLLVGKPPFETSC | 241 | P53350 | |
| LYETEVEVSLMPPCF | 226 | Q02108 | |
| TSFYSKEVPQMCIPG | 756 | P35573 | |
| LVPMACLYTIPTVTK | 1556 | Q6PIF6 |